CareMax to Host Investor Day on March 13
CareMax (NASDAQ: CMAX; CMAXW) will host an Investor Day on March 13, 2023, in Miami at 9:00 am ET. The event will feature discussions on strategic priorities and financial outlook, followed by a Q&A session. Attendees must register in advance through CareMax’s Investor Day site.
Additionally, CareMax will release its fourth quarter and full year 2022 results on March 9, 2023, before market opening, followed by a conference call at 8:30 am ET.
- None.
- None.
The Company will also report fourth quarter and full year 2022 results on
During the investor event, CareMax’s executive leadership team will discuss the Company’s strategic priorities, growth strategy, and financial outlook. Presentations will be followed by a live Q&A session. A live webcast of the Investor Day presentation, along with supporting materials, will also be available on the day of the event on CareMax’s Investor Relations website at ir.caremax.com. A replay of the webcast will be available shortly after the event.
About
Founded in 2011,
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth, strategy and financial performance, the closing of the Steward transaction and the benefits thereof, and the filing of the Company’s periodic reports. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.
Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the Company’s ability to integrate acquired businesses, including the ability to implement business plans, forecasts, and other expectations after the completion of the Steward transaction, the failure to realize anticipated benefits of the Steward transaction or to realize estimated pro forma results and underlying assumptions, the impact of COVID-19 or any variant thereof on the Company's business and results of operation; the availability of sites for de novo centers and the costs of opening such de novo centers; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth, including in new markets; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage and Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; any delay, modification or cancellation of government contracts; the Company's future capital requirements and sources and uses of cash, including funds to satisfy its liquidity needs and the Company’s ability to comply with the covenants under its credit agreement; the Company's ability to recruit and retain qualified team members and independent physicians; and risks related to future acquisitions. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223005227/en/
Investor Relations
VP Investor Relations
(847) 924-8980
samantha.swerdlin@caremax.com
Media
(305) 542-8855
christine@thinkbsg.com
Source:
FAQ
What date is CareMax's Investor Day?
What time will the Investor Day start?
How can I register for the Investor Day?
When will CareMax report its fourth quarter and full year 2022 results?
What time is the conference call for the financial results?